SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Igen Networks Corp. – ‘10-K’ for 12/31/20 – ‘EX-101.CAL’

On:  Wednesday, 3/31/21, at 4:29pm ET   ·   For:  12/31/20   ·   Accession #:  1640334-21-741   ·   File #:  0-55289

Previous ‘10-K’:  ‘10-K’ on 5/29/20 for 12/31/19   ·   Next:  ‘10-K’ on 3/31/22 for 12/31/21   ·   Latest:  ‘10-K’ on 4/17/23 for 12/31/22

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/31/21  Igen Networks Corp.               10-K       12/31/20   74:4.3M                                   Pubco Reporting … Inc/FA

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    461K 
 2: EX-21       Subsidiaries List                                   HTML     18K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     23K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     19K 
11: R1          Cover                                               HTML     58K 
12: R2          Consolidated Balance Sheets                         HTML     83K 
13: R3          Consolidated Balance Sheets (Parenthetical)         HTML     51K 
14: R4          Consolidated Statements of Operations               HTML     77K 
15: R5          Consolidated Statements of Redeemable Convertible   HTML     96K 
                Preferred stock and Stockholders Deficit                         
16: R6          Consolidated Statements of Cash Flows               HTML    116K 
17: R7          Organization and Description of Business            HTML     26K 
18: R8          Summary of Significant Accounting Policies          HTML     70K 
19: R9          Accounts and Other Receivables                      HTML     24K 
20: R10         Goodwill                                            HTML     21K 
21: R11         Accounts Payable and Accrued Liabilities            HTML     27K 
22: R12         Convertible Debentures and Notes Payable            HTML     45K 
23: R13         Derivative Liabilities                              HTML     43K 
24: R14         Related Party Transactions                          HTML     23K 
25: R15         Redeemable Preferred Stock and Stockholders         HTML     47K 
                Deficit                                                          
26: R16         Share Purchase Warrants                             HTML     35K 
27: R17         Stock Options                                       HTML     48K 
28: R18         Segments                                            HTML     21K 
29: R19         Risk and Uncertainities                             HTML     23K 
30: R20         Income Taxes                                        HTML     54K 
31: R21         Commitments and Contingencies                       HTML     29K 
32: R22         Restatements                                        HTML     29K 
33: R23         Subsequent Events                                   HTML     26K 
34: R24         Summary of Significant Accounting Policies          HTML     96K 
                (Policies)                                                       
35: R25         Summary of Significant Accounting Policies          HTML     21K 
                (Tables)                                                         
36: R26         Accounts and Other Receivables (Tables)             HTML     24K 
37: R27         Accounts Payable and Accrued Liabilities (Tables)   HTML     27K 
38: R28         Convertible Debentures and Notes Payable (Tables)   HTML     31K 
39: R29         Derivative Liabilities (Tables)                     HTML     45K 
40: R30         Share Purchase Warrants (Tables)                    HTML     34K 
41: R31         Stock Options (Tables)                              HTML     48K 
42: R32         Income Taxes (Tables)                               HTML     58K 
43: R33         Restatements (Tables)                               HTML     30K 
44: R34         Organization and Description of Business (Details   HTML     23K 
                Narrative)                                                       
45: R35         Summary of Significant Accounting Policies          HTML     27K 
                (Details)                                                        
46: R36         Summary of Significant Accounting Policies          HTML     31K 
                (Details Narrative)                                              
47: R37         Accounts and Other Receivables (Details)            HTML     26K 
48: R38         Goodwill (Details Narrative)                        HTML     21K 
49: R39         Accounts Payable and Accrued Liabilities (Details)  HTML     33K 
50: R40         Convertible Debentures and Notes Payable (Details)  HTML     43K 
51: R41         Convertible Debentures and Notes Payable (Details   HTML    111K 
                Narrative)                                                       
52: R42         Derivative Liabilities (Details)                    HTML     30K 
53: R43         Derivative Liabilities (Details 1)                  HTML     24K 
54: R44         Derivative Liabilities (Details 2)                  HTML     41K 
55: R45         Related Party Transactions (Details Narrative)      HTML     35K 
56: R46         Redeemable Preferred Stock and Stockholders         HTML    115K 
                Deficit (Details Narrative)                                      
57: R47         Share Purchase Warrants (Details)                   HTML     42K 
58: R48         Share Purchase Warrants (Details 1)                 HTML     32K 
59: R49         Share Purchase Warrants (Details Narrative)         HTML     26K 
60: R50         Stock Options (Details)                             HTML     46K 
61: R51         Stock Options (Details 1)                           HTML     50K 
62: R52         Stock Options (Details Narrative)                   HTML     44K 
63: R53         Risks Uncertainties (Details Narrative)             HTML     25K 
64: R54         Income Taxes (Details)                              HTML     44K 
65: R55         Income Taxes (Details 1)                            HTML     47K 
66: R56         Income Taxes (Details 2)                            HTML     35K 
67: R57         Income Taxes (Details 3)                            HTML     26K 
68: R58         Income Taxes (Details Narrative)                    HTML     29K 
69: R59         Commitments and Contingencies (Details Narrative)   HTML     27K 
70: R60         Restatements (Details)                              HTML     39K 
71: R61         Subsequent Events (Details Narrative)               HTML     88K 
73: XML         IDEA XML File -- Filing Summary                      XML    133K 
72: EXCEL       IDEA Workbook of Financial Reports                  XLSX     89K 
 5: EX-101.INS  XBRL Instance -- igen-20201231                       XML   1.13M 
 8: EX-101.CAL  XBRL Calculations -- igen-20201231_cal               XML    130K 
10: EX-101.DEF  XBRL Definitions -- igen-20201231_def                XML    552K 
 7: EX-101.LAB  XBRL Labels -- igen-20201231_lab                     XML    932K 
 9: EX-101.PRE  XBRL Presentations -- igen-20201231_pre              XML    792K 
 6: EX-101.SCH  XBRL Schema -- igen-20201231                         XSD    182K 
74: ZIP         XBRL Zipped Folder -- 0001640334-21-000741-xbrl      Zip    131K

‘EX-101.CAL’   —   XBRL Calculations — igen-20201231_cal

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" standalone="yes" encoding="windows-1252"?>
<!-- XBRL Document Created with XBRLMaster -->
<!-- Version: 2.3.08 -->
<!-- Based on XBRL 2.1 -->
<!-- Date of creation: 03/31/2021 -->
<!-- Software architectural design and coding: Dipendra K. Singh -->
<!-- Copyright (c) 2021 I-NET Business Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://igen.com/role/Cover" xlink:href="igen-20201231.xsd#Cover" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/ConsolidatedBalanceSheets" xlink:href="igen-20201231.xsd#ConsolidatedBalanceSheets" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="igen-20201231.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/ConsolidatedStatementsOfOperations" xlink:href="igen-20201231.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" xlink:href="igen-20201231.xsd#ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="igen-20201231.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/OrganizationAndDescriptionOfBusiness" xlink:href="igen-20201231.xsd#OrganizationAndDescriptionOfBusiness" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="igen-20201231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/AccountsAndOtherReceivables" xlink:href="igen-20201231.xsd#AccountsAndOtherReceivables" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/Goodwill" xlink:href="igen-20201231.xsd#Goodwill" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="igen-20201231.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/ConvertibleDebenturesAndNotesPayable" xlink:href="igen-20201231.xsd#ConvertibleDebenturesAndNotesPayable" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/DerivativeLiabilities" xlink:href="igen-20201231.xsd#DerivativeLiabilities" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/RelatedPartyTransactions" xlink:href="igen-20201231.xsd#RelatedPartyTransactions" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficit" xlink:href="igen-20201231.xsd#RedeemablePreferredStockAndStockholdersDeficit" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/SharePurchaseWarrants" xlink:href="igen-20201231.xsd#SharePurchaseWarrants" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/StockOptions" xlink:href="igen-20201231.xsd#StockOptions" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/Segments" xlink:href="igen-20201231.xsd#Segments" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/RiskAndUncertainities" xlink:href="igen-20201231.xsd#RiskAndUncertainities" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/IncomeTaxes" xlink:href="igen-20201231.xsd#IncomeTaxes" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/CommitmentsAndContingencies" xlink:href="igen-20201231.xsd#CommitmentsAndContingencies" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/Restatements" xlink:href="igen-20201231.xsd#Restatements" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/SubsequentEvents" xlink:href="igen-20201231.xsd#SubsequentEvents" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="igen-20201231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="igen-20201231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/AccountsAndOtherReceivablesTables" xlink:href="igen-20201231.xsd#AccountsAndOtherReceivablesTables" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="igen-20201231.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/ConvertibleDebenturesAndNotesPayableTables" xlink:href="igen-20201231.xsd#ConvertibleDebenturesAndNotesPayableTables" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/DerivativeLiabilitiesTables" xlink:href="igen-20201231.xsd#DerivativeLiabilitiesTables" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/SharePurchaseWarrantsTables" xlink:href="igen-20201231.xsd#SharePurchaseWarrantsTables" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/StockOptionsTables" xlink:href="igen-20201231.xsd#StockOptionsTables" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/IncomeTaxesTables" xlink:href="igen-20201231.xsd#IncomeTaxesTables" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/RestatementsTables" xlink:href="igen-20201231.xsd#RestatementsTables" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" xlink:href="igen-20201231.xsd#OrganizationAndDescriptionOfBusinessDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:href="igen-20201231.xsd#SummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="igen-20201231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/AccountsAndOtherReceivablesDetails" xlink:href="igen-20201231.xsd#AccountsAndOtherReceivablesDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/GoodwillDetailsNarrative" xlink:href="igen-20201231.xsd#GoodwillDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:href="igen-20201231.xsd#AccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetails" xlink:href="igen-20201231.xsd#ConvertibleDebenturesAndNotesPayableDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative" xlink:href="igen-20201231.xsd#ConvertibleDebenturesAndNotesPayableDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/DerivativeLiabilitiesDetails" xlink:href="igen-20201231.xsd#DerivativeLiabilitiesDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/DerivativeLiabilitiesDetails1" xlink:href="igen-20201231.xsd#DerivativeLiabilitiesDetails1" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/DerivativeLiabilitiesDetails2" xlink:href="igen-20201231.xsd#DerivativeLiabilitiesDetails2" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="igen-20201231.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" xlink:href="igen-20201231.xsd#RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/SharePurchaseWarrantsDetails" xlink:href="igen-20201231.xsd#SharePurchaseWarrantsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/SharePurchaseWarrantsDetails1" xlink:href="igen-20201231.xsd#SharePurchaseWarrantsDetails1" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/SharePurchaseWarrantsDetailsNarrative" xlink:href="igen-20201231.xsd#SharePurchaseWarrantsDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/StockOptionsDetails" xlink:href="igen-20201231.xsd#StockOptionsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/StockOptionsDetails1" xlink:href="igen-20201231.xsd#StockOptionsDetails1" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/StockOptionsDetailsNarrative" xlink:href="igen-20201231.xsd#StockOptionsDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/RisksUncertaintiesDetailsNarrative" xlink:href="igen-20201231.xsd#RisksUncertaintiesDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/IncomeTaxesDetails" xlink:href="igen-20201231.xsd#IncomeTaxesDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/IncomeTaxesDetails1" xlink:href="igen-20201231.xsd#IncomeTaxesDetails1" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/IncomeTaxesDetails2" xlink:href="igen-20201231.xsd#IncomeTaxesDetails2" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/IncomeTaxesDetails3" xlink:href="igen-20201231.xsd#IncomeTaxesDetails3" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/IncomeTaxesDetailsNarrative" xlink:href="igen-20201231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="igen-20201231.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/RestatementsDetails" xlink:href="igen-20201231.xsd#RestatementsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://igen.com/role/SubsequentEventsDetailsNarrative" xlink:href="igen-20201231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/Cover" xlink:title="00000001 - Document - Document and Entity Information"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/ConsolidatedBalanceSheets" xlink:title="000002 - Statement - Consolidated Balance Sheets">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="loc_us-gaapAccountsAndOtherReceivablesNetCurrent"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsAndOtherReceivablesNetCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent"/>
<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets"/>
<link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill"/>
<link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent"/>
<link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent"/>
<link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaapConvertibleNotesPayableCurrent"/>
<link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapConvertibleNotesPayableCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesCurrent"/>
<link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDerivativeLiabilitiesCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent"/>
<link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities"/>
<link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="loc_us-gaapConvertibleDebtNoncurrent"/>
<link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapConvertibleDebtNoncurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaapNotesPayableRelatedPartiesNoncurrent"/>
<link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapNotesPayableRelatedPartiesNoncurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="igen-20201231.xsd#igen_DeferredRevenueNetOfContractAssetsAndCurrentPortion" xlink:label="loc_igenDeferredRevenueNetOfContractAssetsAndCurrentPortion"/>
<link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_igenDeferredRevenueNetOfContractAssetsAndCurrentPortion" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity"/>
<link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity"/>
<link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="000003 - Statement - Consolidated Balance Sheets (Parenthetical)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/ConsolidatedStatementsOfOperations" xlink:title="000004 - Statement - Consolidated Statements of Operations">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues"/>
<link:loc xlink:type="locator" xlink:href="igen-20201231.xsd#igen_SalesOther" xlink:label="loc_igenSalesOther"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_igenSalesOther" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="igen-20201231.xsd#igen_SalesServices" xlink:label="loc_igenSalesServices"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_igenSalesServices" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue"/>
<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees"/>
<link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLaborRelatedExpenses" xlink:label="loc_us-gaapOtherLaborRelatedExpenses"/>
<link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapOtherLaborRelatedExpenses" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense"/>
<link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:label="loc_us-gaapEmployeeBenefitsAndShareBasedCompensation"/>
<link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapEmployeeBenefitsAndShareBasedCompensation" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss"/>
<link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1"/>
<link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccretionExpense" xlink:label="loc_us-gaapAccretionExpense"/>
<link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapAccretionExpense" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" xlink:label="loc_us-gaapEmbeddedDerivativeGainLossOnEmbeddedDerivativeNet"/>
<link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapEmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt"/>
<link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense"/>
<link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestIncomeExpenseAfterProvisionForLoanLoss" xlink:label="loc_us-gaapInterestIncomeExpenseAfterProvisionForLoanLoss"/>
<link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapInterestIncomeExpenseAfterProvisionForLoanLoss" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
<link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" weight="1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" xlink:title="000005 - Statement - Consolidated Statements of Redeemable Convertible Preferred stock and Stockholders Deficit"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="000006 - Statement - Consolidated Statements of Cash Flows">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccretionExpense" xlink:label="loc_us-gaapAccretionExpense"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAccretionExpense" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="igen-20201231.xsd#igen_ChangeInFairValueOfDerivativeLiabilities" xlink:label="loc_igenChangeInFairValueOfDerivativeLiabilities"/>
<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_igenChangeInFairValueOfDerivativeLiabilities" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="igen-20201231.xsd#igen_InterestChargeForDerivativeLiabilitiesInExcessOfFaceAmountOfDebt" xlink:label="loc_igenInterestChargeForDerivativeLiabilitiesInExcessOfFaceAmountOfDebt"/>
<link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_igenInterestChargeForDerivativeLiabilitiesInExcessOfFaceAmountOfDebt" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt"/>
<link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="igen-20201231.xsd#igen_SharesIssuedForServices" xlink:label="loc_igenSharesIssuedForServices"/>
<link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_igenSharesIssuedForServices" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation"/>
<link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsAndOtherReceivables"/>
<link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsAndOtherReceivables" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories"/>
<link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense"/>
<link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DecreaseInRestrictedCash" xlink:label="loc_us-gaapDecreaseInRestrictedCash"/>
<link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDecreaseInRestrictedCash" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
<link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredRevenue"/>
<link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredRevenue" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
<link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable"/>
<link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable"/>
<link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt"/>
<link:calculationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock"/>
<link:calculationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashPeriodIncreaseDecrease"/>
<link:calculationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1"/>
<link:calculationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/OrganizationAndDescriptionOfBusiness" xlink:title="000007 - Disclosure - Organization and Description of Business"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="000008 - Disclosure - Summary of Significant Accounting Policies"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/AccountsAndOtherReceivables" xlink:title="000009 - Disclosure - Accounts and Other Receivables"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/Goodwill" xlink:title="000010 - Disclosure - Goodwill"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="000011 - Disclosure - Accounts Payable and Accrued Liabilities"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/ConvertibleDebenturesAndNotesPayable" xlink:title="000012 - Disclosure - Convertible Debentures and Notes Payable"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/DerivativeLiabilities" xlink:title="000013 - Disclosure - Derivative Liabilities"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/RelatedPartyTransactions" xlink:title="000014 - Disclosure - Related Party Transactions"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficit" xlink:title="000015 - Disclosure - Redeemable Preferred Stock and Stockholders Deficit"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/SharePurchaseWarrants" xlink:title="000016 - Disclosure - Share Purchase Warrants"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/StockOptions" xlink:title="000017 - Disclosure - Stock Options"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/Segments" xlink:title="000018 - Disclosure - Segments"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/RiskAndUncertainities" xlink:title="000019 - Disclosure - Risk and Uncertainities"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/IncomeTaxes" xlink:title="000020 - Disclosure - Income Taxes"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/CommitmentsAndContingencies" xlink:title="000021 - Disclosure - Commitments and Contingencies"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/Restatements" xlink:title="000022 - Disclosure - Restatements"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/SubsequentEvents" xlink:title="000023 - Disclosure - Subsequent Events"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="000024 - Disclosure - Summary of Significant Accounting Policies (Policies)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="000025 - Disclosure - Summary of Significant Accounting Policies (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/AccountsAndOtherReceivablesTables" xlink:title="000026 - Disclosure - Accounts and Other Receivables (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="000027 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/ConvertibleDebenturesAndNotesPayableTables" xlink:title="000028 - Disclosure - Convertible Debentures and Notes Payable (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/DerivativeLiabilitiesTables" xlink:title="000029 - Disclosure - Derivative Liabilities (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/SharePurchaseWarrantsTables" xlink:title="000030 - Disclosure - Share Purchase Warrants (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/StockOptionsTables" xlink:title="000031 - Disclosure - Stock Options (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/IncomeTaxesTables" xlink:title="000032 - Disclosure - Income Taxes (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/RestatementsTables" xlink:title="000033 - Disclosure - Restatements (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" xlink:title="000034 - Disclosure - Organization and Description of Business (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:title="000035 - Disclosure - Summary of Significant Accounting Policies (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="000036 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/AccountsAndOtherReceivablesDetails" xlink:title="000037 - Disclosure - Accounts and Other Receivables (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/GoodwillDetailsNarrative" xlink:title="000038 - Disclosure - Goodwill (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:title="000039 - Disclosure - Accounts Payable and Accrued Liabilities (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetails" xlink:title="000040 - Disclosure - Convertible Debentures and Notes Payable (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative" xlink:title="000041 - Disclosure - Convertible Debentures and Notes Payable (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/DerivativeLiabilitiesDetails" xlink:title="000042 - Disclosure - Derivative Liabilities (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/DerivativeLiabilitiesDetails1" xlink:title="000043 - Disclosure - Derivative Liabilities (Details 1)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/DerivativeLiabilitiesDetails2" xlink:title="000044 - Disclosure - Derivative Liabilities (Details 2)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="000045 - Disclosure - Related Party Transactions (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" xlink:title="000046 - Disclosure - Redeemable Preferred Stock and Stockholders Deficit (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/SharePurchaseWarrantsDetails" xlink:title="000047 - Disclosure - Share Purchase Warrants (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/SharePurchaseWarrantsDetails1" xlink:title="000048 - Disclosure - Share Purchase Warrants (Details 1)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/SharePurchaseWarrantsDetailsNarrative" xlink:title="000049 - Disclosure - Share Purchase Warrants (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/StockOptionsDetails" xlink:title="000050 - Disclosure - Stock Options (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/StockOptionsDetails1" xlink:title="000051 - Disclosure - Stock Options (Details 1)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/StockOptionsDetailsNarrative" xlink:title="000052 - Disclosure - Stock Options (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/RisksUncertaintiesDetailsNarrative" xlink:title="000053 - Disclosure - Risks Uncertainties (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/IncomeTaxesDetails" xlink:title="000054 - Disclosure - Income Taxes (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/IncomeTaxesDetails1" xlink:title="000055 - Disclosure - Income Taxes (Details 1)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/IncomeTaxesDetails2" xlink:title="000056 - Disclosure - Income Taxes (Details 2)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/IncomeTaxesDetails3" xlink:title="000057 - Disclosure - Income Taxes (Details 3)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/IncomeTaxesDetailsNarrative" xlink:title="000058 - Disclosure - Income Taxes (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="000059 - Disclosure - Commitments and Contingencies (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/RestatementsDetails" xlink:title="000060 - Disclosure - Restatements (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://igen.com/role/SubsequentEventsDetailsNarrative" xlink:title="000061 - Disclosure - Subsequent Events (Details Narrative)"/>
</link:linkbase>

↑Top
Filing Submission 0001640334-21-000741   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Tue., Apr. 30, 7:07:37.0pm ET